These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3953123)

  • 1. [Redundancy reduction in laboratory studies--evaluated by the laboratory diagnostic follow-up program of an epidemiologic cardiovascular study].
    Gerhard W; Hempel WE; Richter K; Vogelreuter K; Wagenknecht CU
    Z Gesamte Inn Med; 1986 Jan; 41(2):34-6. PubMed ID: 3953123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methodology and organization of a laboratory diagnostic study program within the scope of epidemiologic cardiovascular studies exemplified by the Berlin EMBO-Cor research project].
    Gerhard W; Hempel WE; Richter K; Wagenknecht CU
    Z Gesamte Inn Med; 1988 Feb; 43(4):93-5. PubMed ID: 3376507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value and rank of diagnostic laboratory parameters in cardiovascular diseases. Results of multivariant and discriminant analyses of the Berlin EBMO-Cor population study].
    Gerhard W; Hempel WE; Hermann K; Richter K; Wagenknecht CU
    Z Kardiol; 1987 Jan; 76(1):44-50. PubMed ID: 3564617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of laboratory diagnostic study parameters of the hepatobiliary system in the evaluation of cardiovascular diseases--results of cross sectional and longitudinal studies in patients with suspicious cardiovascular findings in an epidemiologic follow-up study].
    Richter K; Hempel WE; Gerhard W; Vogelreuter K; Wagenknecht CU
    Z Gesamte Inn Med; 1986 Aug; 41(15):413-8. PubMed ID: 3490068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative biochemical parameters in deceased and living patients in a follow-up intervention study of cardiovascular patients].
    Gerhard W; Hempel WE; Richter K; Vogelreuter K; Wagenknecht CU
    Z Alternsforsch; 1987; 42(2):101-10. PubMed ID: 3590837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of pathologic laboratory values in patients with cardiovascular diseases--consequences for diagnosis in general practice].
    Gerhard W; Hempel WE; Gaber E; Richter K; Wagenknecht CU
    Z Gesamte Inn Med; 1987 Dec; 42(23):670-3. PubMed ID: 3445649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal changes in iron and protein status of elderly Europeans. SENECA Investigators.
    Lesourd B; Decarli B; Dirren H
    Eur J Clin Nutr; 1996 Jul; 50 Suppl 2():S16-24. PubMed ID: 8841781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of prognosis with Markov chains in chronic cardiovascular diseases in relation to various therapies].
    Grimm J; Hempel WE; Gerst H; Richter K; Hempel B
    Z Gesamte Inn Med; 1988 Apr; 43(8):205-9. PubMed ID: 3400296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of therapy schedule on hospitalization frequency and prognosis in heart failure in 3 yrs. observations].
    Sidorowicz K; Tkacz E; Poloński L
    Pol Merkur Lekarski; 2002 Jan; 12(67):30-5. PubMed ID: 11957798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
    Margolis KL; Manson JE; Greenland P; Rodabough RJ; Bray PF; Safford M; Grimm RH; Howard BV; Assaf AR; Prentice R;
    Arch Intern Med; 2005 Mar; 165(5):500-8. PubMed ID: 15767524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of Scopolamine Hydrobromide Trihydrate (CAS No. 6533-68-2) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Mar; 445():1-277. PubMed ID: 12594530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lucent-Takes-Heart cardiovascular health management program. Successful workplace screening.
    Guico-Pabia CJ; Cioffi L; Shoner LG
    AAOHN J; 2002 Aug; 50(8):365-72. PubMed ID: 12227211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk reduction and factors influencing loss to follow-up in the coronary health improvement project.
    Merrill RM; Aldana SG
    Med Sci Monit; 2008 Apr; 14(4):PH17-25. PubMed ID: 18376357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the initial results obtained in the Program for Quality Control in Hematology. Organized by the Spanish Associations of Hematology and Hemotherapy, and Clinical Biopathology].
    Aznar J; Teruel M; Bolufer P
    Sangre (Barc); 1982; 27(5):973-81. PubMed ID: 7167852
    [No Abstract]   [Full Text] [Related]  

  • 15. Young children's cardiovascular stress responses predict resting cardiovascular functioning 2 1/2 years later.
    Treiber FA; Turner JR; Davis H; Thompson W; Levy M; Strong WB
    J Cardiovasc Risk; 1996 Feb; 3(1):95-100. PubMed ID: 8783036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood values in stumptailed macaques (Macaca arctoides) under laboratory conditions.
    Oser F; Lang RE; Vogin EE
    Lab Anim Care; 1970 Jun; 20(3):462-6. PubMed ID: 4247043
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value of elevated white blood cell count in hypertension.
    Schillaci G; Pirro M; Pucci G; Ronti T; Vaudo G; Mannarino MR; Porcellati C; Mannarino E
    Am J Hypertens; 2007 Apr; 20(4):364-9. PubMed ID: 17386341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility and accuracy of clinical laboratory determinations.
    Flokstra JH; Varley AB; Hagans JA
    Am J Med Sci; 1966 Jun; 251(6):646-55. PubMed ID: 5946364
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of cardiovascular events in renal transplant recipients and clinical relevance of modifiable variables.
    Valdés-Cañedo F; Pita-Fernández S; Seijo-Bestilleiro R; Pértega-Díaz S; Alonso-Hernández A; Cillero-Rego S; Fernández-Rivera C; Oliver-García J
    Transplant Proc; 2007 Sep; 39(7):2239-41. PubMed ID: 17889150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.